metricas
covid
Buscar en
Clínica e Investigación en Arteriosclerosis (English Edition)
Toda la web
Inicio Clínica e Investigación en Arteriosclerosis (English Edition) Most often read
Journal Information

Most often read

902
SEA 2024 Standards for Global Control of Vascular Risk
José María Mostaza, Xavier Pintó, Pedro Armario, Luis Masana, José T. Real, Pedro Valdivielso, Teresa Arrobas-Velilla, Ramón Baeza-Trinidad, ... José Puzo
Clin Investig Arterioscler. 2024;36:133-94
902
Full text access
Open Article
464
Detection of subclinical atherosclerosis using vascular ultrasound as a vascular risk assessment method. Simplified protocol
Manuel Frías Vargas, Estíbaliz Jarauta
Clin Investig Arterioscler. 2024;36:195-9
464
Full text access
Open Article
271
Cardiovascular prevention in diabetes mellitus. Is it appropriate to speak of moderate or intermediate risk?
Sergio Martínez-Hervás, José T. Real, Rafael Carmena, Juan F. Ascaso
Clin Investig Arterioscler. 2024;36:80-5
271
Full text access
Open Article
216
Influence of triglyceride concentration in lipoprotein(a) as a function of dyslipidemia
Victoria Marco-Benedí, Ana Cenarro, Martín Laclaustra, Pilar Calmarza, Ana M. Bea, Àlex Vila, Carlos Morillas-Ariño, José Puzo, ... Fernando Civeira
Clin Investig Arterioscler. 2024;36:71-7
216
Full text access
Open Article
190
Thrombotic risk assessed by PAI-1 in patients with COVID-19: The influence of hyperglycemia and diabetes mellitus
Lourdes Basurto, Leticia Manuel-Apolinar, Ariadna Robledo, Sean O’Leary, Carlos Martínez-Murillo, Lina Ivette Medina-Ortíz, Mario German Montes Osorio, Julio Zarazua, ... Juan Carlos Anda-Garay
Clin Investig Arterioscler. 2024;36:201-9
190
Full text access
Open Article
156
Is Helicobacter pylori a new kid on the block?
Manuel Vázquez-Carrera
Clin Investig Arterioscler. 2024;36:78-9
156
Full text access
Open Article
134
Multizonal observational study conducted by clinical practitioners on Repatha® use in patients with hyperlipidemia (ZERBINI): Colombian results
Heidy M. Roncancio, Julián R. Lugo-Peña, Ángel A. García, Janeth Leal, Carlos A. Hoyos, Johnny A. Beltrán, César L. Cruz, Carol Paez-Cano, ... Eduardo Contreras
Clin Investig Arterioscler. 2024;36:22-32
134
Full text access
Open Article
49
Prof. Rafael Carmena Rodríguez
Juan F Ascaso
Clin Investig Arterioscler. 2024;36:267-8
49
Full text access
Open Article
37
Thrombotic risk associated with COVID-19 and diabetes; Is PAI-1 the link?
José A. Páramo
Clin Investig Arterioscler. 2024;36:227-8
37
5
Clinical profile of severe hypercholesterolemia in 156,000 adults in primary care
Teresa Gijón-Conde, Carolina Ferré Sánchez, Isabel Ibáñez Delgado, Berenice Rodríguez Jiménez, José R. Banegas
Clin Investig Arterioscler. 2024;36:1-11
5
4
New atherogenic index for the prediction of carotid atherosclerosis based on the non-ultrasensitive c-reactive protein/HDL ratio
Óscar Fabregat-Andrés, Pilar Pérez-de-Lucía, Victor E. Vallejo-García, Pablo Vera-Ivars, Alfonso A. Valverde-Navarro, José María Tormos
Clin Investig Arterioscler. 2024;36:12-21
4
3
Lipoprotein (a) is a predictor of non-achievement of LDL-C goals in patients with chronic heart disease
José Javier Gómez-Barrado, Paula Gómez-Turégano, María Beltrán Moreno, Ana Isabel Fernández-Chamorro, Benjamín Roque Rodríguez, Zineb Kounka
Clin Investig Arterioscler. 2024;36:278-85
3
es en pt

¿Es usted profesional sanitario apto para prescribir o dispensar medicamentos?

Are you a health professional able to prescribe or dispense drugs?

Você é um profissional de saúde habilitado a prescrever ou dispensar medicamentos